McCoy R, Haviland D L, Molmenti E P, Ziambaras T, Wetsel R A, Perlmutter D H
Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
J Exp Med. 1995 Jul 1;182(1):207-17. doi: 10.1084/jem.182.1.207.
Although the classical chemotactic receptor for complement anaphylatoxin C5a has been associated with polymorphonuclear and mononuclear phagocytes, several recent studies have indicated that this receptor is expressed on nonmyeloid cells including human endothelial cells, vascular smooth muscle cells, bronchial and alveolar epithelial cells, hepatocytes, and in the human hepatoma cell line HepG2. In this study, we examined the possibility that other members of the chemotactic receptor family are expressed in HepG2 cells and human liver, and the possibility that such receptors mediate changes in acute phase gene expression in HepG2 cells. Using polymerase chain reaction (PCR) amplification of HepG2 mRNA with primers based on highly conserved regions of the chemotactic subgroup of the G protein-coupled receptor family, we identified a PCR fragment from the formyl-methionyl-leucyl-phenylalanine (FMLP) receptor, as well as one from the C5a receptor. Immunostaining with antipeptide antisera to FMLPR confirmed the presence of this receptor in HepG2 cells. Receptor binding studies showed specific saturable binding of a radioiodinated FMLP analogue to HepG2 cells (Kd approximately 2.47 nM; R approximately 6 x 10(3) plasma membrane receptors per cell). In situ hybridization analysis showed the presence of FMLPR mRNA in parenchymal cells of the human liver in vivo. Both C5a and FMLP mediated concentration- and time-dependent changes in synthesis of acute phase proteins in HepG2 cells including increases in complement C3, factor B, and alpha 1-antichymotrypsin, as well as concomitant decreases in albumin and transferrin synthesis. The effects of C5a and FMLP on the synthesis of these acute phase proteins was evident at concentrations as low as 1 nM, and they were specifically blocked by antipeptide antisera for the corresponding receptor. In contrast to the effect of other mediators of hepatic acute phase gene regulation, such as interleukin 6, the effects of C5a and FMLP were reversed by increased concentrations well above the saturation point of the respective receptor. These results suggest that acute phase gene regulation by C5a and FMLP is desensitized at high concentrations, a property that is unique among the several known mechanisms for hepatic acute phase gene regulation.
虽然补体过敏毒素C5a的经典趋化受体一直与多形核细胞和单核吞噬细胞相关,但最近的几项研究表明,该受体在包括人内皮细胞、血管平滑肌细胞、支气管和肺泡上皮细胞、肝细胞以及人肝癌细胞系HepG2在内的非髓样细胞上表达。在本研究中,我们检测了趋化受体家族的其他成员是否在HepG2细胞和人肝脏中表达,以及这些受体是否介导HepG2细胞中急性期基因表达的变化。使用基于G蛋白偶联受体家族趋化亚组高度保守区域的引物对HepG2 mRNA进行聚合酶链反应(PCR)扩增,我们从甲酰甲硫氨酰亮氨酰苯丙氨酸(FMLP)受体以及C5a受体中鉴定出一个PCR片段。用针对FMLPR的抗肽抗血清进行免疫染色证实了该受体在HepG2细胞中的存在。受体结合研究表明,一种放射性碘化FMLP类似物与HepG2细胞存在特异性饱和结合(解离常数约为2.47 nM;每个细胞约有6×10³个质膜受体)。原位杂交分析表明,体内人肝脏实质细胞中存在FMLPR mRNA。C5a和FMLP均介导HepG2细胞中急性期蛋白合成的浓度和时间依赖性变化,包括补体C3、B因子和α1-抗糜蛋白酶的增加,以及白蛋白和转铁蛋白合成的同时减少。C5a和FMLP对这些急性期蛋白合成的影响在低至1 nM的浓度下就很明显,并且它们被相应受体的抗肽抗血清特异性阻断。与肝脏急性期基因调节的其他介质(如白细胞介素6)的作用相反,C5a和FMLP的作用在远高于各自受体饱和点的浓度增加时会逆转。这些结果表明,C5a和FMLP对急性期基因的调节在高浓度下会脱敏,这是几种已知的肝脏急性期基因调节机制中独特的特性。